Sign in

CIK 0001635088

  • Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
Operating
EIN
981173944
Phone
+44 12955950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 1,364 shares (to pay taxes)
  2. 4 Other disposition CFO disposed of 2,360 shares (other)
  3. 4 Other disposition President & COO disposed of 16,549 shares (other)
  4. 4 Other disposition Chief Accounting Officer disposed of 1,415 shares (other)
  5. 4 Other disposition CEO disposed of 11,318 shares (other)
  6. 4 Other disposition CFO disposed of 2,360 shares (other)
  7. 4 Other disposition President & COO disposed of 18,261 shares (other)
  8. 4 Other disposition CEO disposed of 12,489 shares (other)
  9. 4 Other disposition Chief Accounting Officer disposed of 1,563 shares (other)
  10. 4 Other disposition Director disposed of 687 shares (other)
  11. 4 Grant or award Director acquired 2,269 shares (grant or award)
  12. 4 Grant or award Director acquired 1,226 shares (grant or award)
  13. 4 Grant or award Director acquired 1,269 shares (grant or award)
  14. 4 Planned sale Chief Operating Officer sold 1,200,000 shares at an average $10.43 ($12,520,990)
  15. 4 Open-market buy Director bought 1,526,316 shares at $38.00 ($58,000,008)
  16. 4 Other disposition CFO disposed of 2,483 shares (other)
  17. 4 Open-market sale Director sold 6,896,144 shares at $11.55 ($79,650,463)
  18. 4 Open-market sale 10% owner sold 10,000,000 shares at $12.60 ($126,000,000)
  19. 4 Open-market sale Director sold 10,000,000 shares at $11.55 ($115,500,000)
  20. 4 Open-market sale 10% owner sold 10,000,000 shares at $11.55 ($115,500,000)

Page 15 of 26 · 511 filings